De novo renal cell carcinoma in a kidney allograft treatment with percutaneous radiofrequency ablation: a case report
Clinical Practice
Marius Paškonis
Laimutis Andreika
Linas Andreika
Jonas Jurgaitis
Feliksas Jankevičius
Kęstutis Strupas
Published 2015-12-29
https://doi.org/10.15388/LietChirur.2015.4.9205
PDF

Keywords

De novo allograft tumor
percutaneous radiofrequency ablation
renal cell carcinoma

How to Cite

1.
Paškonis M, Andreika L, Andreika L, Jurgaitis J, Jankevičius F, Strupas K. De novo renal cell carcinoma in a kidney allograft treatment with percutaneous radiofrequency ablation: a case report. LS [Internet]. 2015Dec.29 [cited 2021Dec.3];14(4):279-83. Available from: https://www.journals.vu.lt/lietuvos-chirurgija/article/view/9205

Abstract

The incidence of malignant tumors in renal allograft recipients is higher than in the general population. Kidney carcinomas represent 4.8% of the tumors in transplant patients. Only 10% of them occur in the transplanted kidney. Graft tumors can be transmitted by donors, metastases from the recipient’s native organs, or de novo development after transplantation. The mean time to diagnosis of the tumor after transplantation is 10 years. We report the case of a 45-year old male patient with an incidental locally confined 15 mm renal cell carcinoma detected in allograft kidney’s lower pole 16 years after the transplanta­tion. The patient successfully underwent a minimally invasive procedure - percutaneous radiofrequency ablation, completely eliminating the tumor and preserving graft function with no signs of early complications. One year after the procedure, there is no evidence of oncological disease recurrence or late complications and the patient maintains an adequate graft function with no need for hemodialysis.

PDF

Please read the Copyright Notice in Journal Policy

Most read articles by the same author(s)

1 2 3 4 5 > >>